Biotech1 month ago
Novartis Sells German Company Morphosys Less Than a Year After Buying It
Novartis plans to sell Morphosys' business, acquired for €2.7 billion in 2023, affecting 330 employees as it closes two factories by 2025. Initially aimed at boosting...